SARS CoV-2 vaccine AND rituximab, timing might be a key for a better vaccine response

Joint Bone Spine. 2021 Dec;88(6):105258. doi: 10.1016/j.jbspin.2021.105258. Epub 2021 Sep 2.
No abstract available

Keywords: COVID; Rituximab; Vaccine.

Publication types

  • Letter

MeSH terms

  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • Rituximab / therapeutic use
  • SARS-CoV-2
  • Severe Acute Respiratory Syndrome*
  • Vaccines*

Substances

  • COVID-19 Vaccines
  • Vaccines
  • Rituximab